Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia
Schizophrenia Research · 2024
DOI: 10.1016/j.schres.2024.06.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Research, 2024. Verfasst von Yaxi Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatry Department, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China; Sleep Medicine Center of Psychiatry Departme…. Hauptthemen laut MEDLINE: Schizophrenia, Gastrointestinal Microbiome, Antipsychotic Agents, Weight Gain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Emerging evidence indicates that gut microbial dysbiosis is associated with the development of antipsychotic-induced weight gain in schizophrenia (SZ). However, the exact taxonomic composition and functionality that constitute the "obesogenic" microbial profile remain elusive. Our retrospective survey identified two groups of the SZ population separated by BMI, with 1/3 of patients developing overweight/obesity after chronic antipsychotic treatment. Based on multi-omics analysis, we observed altered gut microbiota in SZ patients with overweight/obesity, characterized by a reduction in several beneficial bacteria genera, including Bacteroides, Parabacteroides, Akkermansia, and Clostridium. This microbial dysbiosis was accompanied by disrupted energy expenditure and nutritional metabolism, worsened metabolic indices, and reduced levels of beneficial metabolites, e.g. indole-3-carboxylic acid and propionic acid. Moreover, leveraging data from first-episode drug-naïve schizophrenia (FSZ) patients at one-month and one-year follow-up, both artificial neural network and random forest classifier-based prediction models demonstrated a strong ability of microbial profiles to predict antipsychotic-induced weight gain. Importantly, FSZ patients with higher relative abundance of Parabacteria distasonis were less susceptible to antipsychotic-induced weight gain. Thus, gut microbiota could serve as a noninvasive approach to predict antipsychotic-induced weight gain, guiding clinical antipsychotics administration and developing novel therapeutic strategies for weight management in SZ.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Psychiatry Department, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China; Sleep Medicine Center of Psychiatry Department, The First Affiliated Hospital of Jinan University, Guangzhou 51063…
- Radiology Department, Renmin Hospital of Wuhan University, Wuhan 430060, China.
- Department of Endocrinology and Metabolism, Zhujiang Hospital of Southern Medical University, Guangzhou 510280, China; State Key Laboratory of Applied Microbiology Southern China, Guangdong Institute of Microbiology, Gu…
- Psychiatry Department, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
- State Key Laboratory of Applied Microbiology Southern China, Guangdong Institute of Microbiology, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Institute of Microbiology, Guangdong…
- Department of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom.
Zitieren
APA
Liu, Y., Wu, H., Liu, B., Chen, S., Huang, L., Liu, Z., Wang, J., Xie, L., & Wu, X. (2024). Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia. Schizophrenia Research. https://doi.org/10.1016/j.schres.2024.06.040
Vancouver
Liu Y, Wu H, Liu B, Chen S, Huang L, Liu Z, et al. Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia. Schizophrenia Research. 2024. doi:10.1016/j.schres.2024.06.040
BibTeX
@article{Liu2024,
author = {Liu, Yaxi and Wu, Hui and Liu, Bingdong and Chen, Shengyun and Huang, Liujing and Liu, Zhihong and Wang, Jie and Xie, Liwei and Wu, Xiaoli},
title = {Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia},
journal = {Schizophrenia Research},
year = {2024},
doi = {10.1016/j.schres.2024.06.040}
}
EUVIMED